1426 related articles for article (PubMed ID: 25234529)
1. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
Ruggiero SL; Dodson TB; Fantasia J; Goodday R; Aghaloo T; Mehrotra B; O'Ryan F;
J Oral Maxillofac Surg; 2014 Oct; 72(10):1938-56. PubMed ID: 25234529
[TBL] [Abstract][Full Text] [Related]
2. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
Ruggiero SL; Dodson TB; Aghaloo T; Carlson ER; Ward BB; Kademani D
J Oral Maxillofac Surg; 2022 May; 80(5):920-943. PubMed ID: 35300956
[TBL] [Abstract][Full Text] [Related]
3. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX.
Schwartz HC
J Oral Maxillofac Surg; 2015 Mar; 73(3):377. PubMed ID: 25683041
[No Abstract] [Full Text] [Related]
4. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
[TBL] [Abstract][Full Text] [Related]
5. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update.
Chang JI; Hazboun RC; Chang TI
J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315
[No Abstract] [Full Text] [Related]
6. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):2-12. PubMed ID: 19371809
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-related osteonecrosis of the jaw.
Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
[TBL] [Abstract][Full Text] [Related]
8. Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines.
Patel S; Choyee S; Uyanne J; Nguyen AL; Lee P; Sedghizadeh PP; Kumar SK; Lytle J; Shi S; Le AD
Oral Dis; 2012 Oct; 18(7):625-32. PubMed ID: 22420684
[TBL] [Abstract][Full Text] [Related]
9. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
10. [Focus: Drug-related osteonecrosis of the jaw].
Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
[TBL] [Abstract][Full Text] [Related]
11. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
Ruggiero SL; Dodson TB; Assael LA; Landesberg R; Marx RE; Mehrotra B;
Aust Endod J; 2009 Dec; 35(3):119-30. PubMed ID: 19961450
[No Abstract] [Full Text] [Related]
12. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
Dodson TB
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.
Yoneda T; Hagino H; Sugimoto T; Ohta H; Takahashi S; Soen S; Taguchi A; Toyosawa S; Nagata T; Urade M
J Bone Miner Metab; 2010 Jul; 28(4):365-83. PubMed ID: 20333419
[TBL] [Abstract][Full Text] [Related]
14. A review of bisphosphonate-associated osteonecrosis of the jaws and its management.
Lam DK; Sándor GK; Holmes HI; Evans AW; Clokie CM
J Can Dent Assoc; 2007 Jun; 73(5):417-22. PubMed ID: 17555652
[TBL] [Abstract][Full Text] [Related]
15. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
Colella G; Campisi G; Fusco V
J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998
[No Abstract] [Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaw: an overview.
Ruggiero SL
Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
[TBL] [Abstract][Full Text] [Related]
17. [Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice].
Dannemann C; Grätz KW; Zwahlen RA
Schweiz Monatsschr Zahnmed; 2008; 118(2):113-23. PubMed ID: 18361180
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
Fusco V; Santini D; Armento G; Tonini G; Campisi G
Expert Opin Drug Saf; 2016 Jul; 15(7):925-35. PubMed ID: 27074901
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero SL; Fantasia J; Carlson E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
[No Abstract] [Full Text] [Related]
20. Antiresorptive drug-related osteonecrosis of the jaw.
Uyanne J; Calhoun CC; Le AD
Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
